Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Call-On-Doc vs Tablet Health

Call-On-Doc
Graded #299

Higher grade

vs+13.699999999999996
Tablet Health
Graded #495

Lower grade

The verdict

Call-On-Doc takes it — 61.3/100 to 47.6/100.

Call-On-Doc grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Call-On-Doc is a large multi-condition online telehealth service (2M+ patients, 800k+ five-star reviews) offering a GLP-1 weight-loss program.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationCall-On-Doc +2
53
51
Clinical oversightCall-On-Doc +48
85
37
Labs & monitoringCall-On-Doc +4
54
50
FulfillmentCall-On-Doc +26
83
57
Contract termsEven
55
55
Call-On-Doc · left barTablet Health · right bar

The numbers

MetricCall-On-DocTablet Health
WeighScore61.3/10047.6/100
GradeCC
Scorecard rank#299#495
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
Call-On-Doc

Graded #299 · C

Strengths

  • Prescribes branded GLP-1s (Wegovy, Ozempic, Mounjaro, Zepbound, Saxenda)
  • Available in all 50 states plus DC
  • Fast, no-appointment visits usually completed within two hours
  • Patients can use insurance at the pharmacy plus an Rx savings card
  • Large, well-reviewed platform (2M+ patients, 800k+ 5-star reviews)

Where it loses points

  • Specific visit fee and medication pricing not posted on homepage
  • Credit card required for the visit fee
  • Multi-condition focus rather than weight-loss specialist
  • Provider credentials described only generically
Tablet Health

Graded #495 · C

Strengths

  • LegitScript Certified
  • Four named compounding pharmacy partners (Pharmacy Hub, Epiq Scripts, Dr. TelX, Emerad), none with FDA warning letters
  • Oral GLP-1 option for both semaglutide and tirzepatide — uncommon in compounded telehealth
  • Mid-tier pricing starting $179–$299/mo across all four product variants
  • No commitment — cancel anytime

Where it loses points

  • States served not published — you must complete the intake quiz to learn eligibility
  • No founder, CEO, medical director, or pharmacist-in-charge named anywhere
  • No BBB profile found
  • Its Queens NYC pharmacy is 'opening soon' — all dispensing currently routes through external partners
  • FDA issued this company a warning letter dated 19 March 2025; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard